MSD Animal Health has announced the European launch of Activyl, a novel flea and tick treatment containing indoxacarb, an active that is new to animal health and which - uniquely - is activated by flea metabolism.

Activyl is licensed to treat and prevent…

MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.

Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy…

MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.

Bravecto (fluralaner) is the first of a…

MSD Animal Health has launched the Big Flea Guarantee, a new marketing initiative to support its flea and tick treatment for dogs, Bravecto.  

The launch began with a live webcast from the University of Bristol offering advice for pet owners on managing…

MSD Animal Health has announced the launch of The Big Tick Project, both to investigate whether ticks are carrying more pathogens and to raise awareness amongst the public.

The company highlights research which shows that nationally, tick distribution…

MSD Animal Health, in collaboration with the University of Bristol, has launched the Big Tick Project (BTP) for cats, a campaign designed to raise awareness and improve education on the growing risk of ticks and tick-borne diseases in Britain amongst cat…

MSD Animal Health has announced the launch of Bravecto (fluralaner) Spot-On Solution for cats, a spot-on treatment for fleas and ticks effective for 12 weeks following a single dose. 

Amanda Melvin, Senior Product Manager, said: "We’re very excited about…

MSD Animal Health has launched 'No Hiding', a campaign designed to educate pet owners about parasite control and add value to the consultation process by encouraging veterinary nurses and front-of-house staff to get more involved and share their expertise…

MSD Animal Health, maker of Bravecto, is giving advance notice that this year’s Tick Awareness Month will take place in May, in order to give veterinary practices time to apply for a resource pack and get involved.

Last year's event generated…

MSD Animal Health has launched Tick Awareness Month, which takes place in May, with a call for veterinary surgeons and nurses to lobby their local parliamentary candidate to reinstate comprehensive tick control measures in the Pet Travel Scheme. 

The…

Matt Dawson, the former England rugby captain, has lent his support to MSD Animal Health's Big Tick Project, the company's campaign to raise awareness of the health risks from tick bites.

Matt, who contracted Lyme disease early last year, has…

MSD Animal Health has announced the launch of Bravecto Spot-on for Dogs (fluralaner).

The new spot on, which is complementary to the Bravecto dog chew, is the only one to provide 12 week protection for both fleas and ticks, including Rhipicephalus sang…

MSD Animal Health (maker of Bravecto) is asking veterinary surgeons to get involved in the Big Flea Project, described as the UK’s largest piece of academic research into fleas, their prevalence, and the diseases they carry.

The study, which is…

MSD Animal Health has announced the launch of Bravecto Plus, a topical endo- and ectoparasiticide for cats.

Bravecto Plus contains fluralaner (280 mg/ml), an ectoparasiticide which provides systemic activity against ticks (lxodes ricinus) and fleas (

MSD Animal Health and the University of Bristol have published the results of their 'Big Flea Project' research¹, which highlights the ongoing need for flea control, and a need to educate owners about the pathogenic risks fleas present.

For the…

MSD Animal Health has announced that Bravecto Plus has been given a new licence to treat Otodectes Cynotis (ear mites) in cats.

The company points to a study which showed that cats treated Bravecto Plus showed no visible signs of mites at 14 days and…

MSD Animal Health has announced that it is putting additional resources behind LetiFend, its vaccination against disease caused by exposure to Leishmania infantum parasites, including a new veterinary practice leaflet and detailer.

MSD's push is being driven…

MSD Animal Health has launched VetsDeliver, a new service delivering parasite prescriptions direct from the veterinary practice to the pet owner’s home.

Through the new service, which is designed to save clients' time and improve compliance, practices…

MSD Animal Health has set up a pet owner online registration facility for its VetsDeliver service, which delivers parasiticides direct from the vet to the owner.

Designed to help veterinary practices save clients' time and improve compliance, VetsDeliver…

MSD Animal Health has launched its Summer Staycation campaign with a range of resources to help veterinary practices keep their clients safe from parasites while holidaying in the UK.

MSD says the Summer Staycation campaign is designed to support the needs…

MSD has been given approval by the Veterinary Medicines Directorate for an injectable version of Bravecto, its parasiticide for dogs, which lasts a whole year.

This new injectable fluralaner formulation is approved for the immediate and persistent killing…

MSD Animal Health has been granted the marketing authorisation in the UK for Bravecto Triuno, a new formulation of Bravecto (fluralaner) for dogs that targets both external and internal parasites.

Bravecto Triuno is approved for the treatment of tick…

MSD Animal Health is urging vets to reassess their approach to managing neonatal calf diarrhoea, following new evidence showing a rise in resistance to paromomycin.

The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed…

MSD is hosting a free one-hour webinar which will explore the clinical and practical challenges vets face when recommending vaccination as part of a wider scour control programme, at 4pm on Wednesday 3rd September 2025

The webinar, which is exclusively